Restless Leg Syndrome

First Device for RLS-Disrupted Sleep

First Device for RLS-Disrupted Sleep Approved

Sensory Medical announced that the FDA has granted commercial clearance for Relaxis, the first nonpharmacological medical device to improve the quality of sleep in patients with primary Restless Legs Syndrome (RLS).

Drug Therapies for Restless Legs Syndrome

Drug Therapies for Restless Legs Syndrome

Willis-Ekbom disease, otherwise known as restless legs syndrome, is a neurologic disorder that affects up to 10% of Americans. Individuals with RLS develop irresistible urges to move their legs accompanied by unusual or unpleasant sensations in the legs.